Echometrix Awarded Key Ultrasound Patent

Madison, WI – Echometrix, LLC today announced that the U.S. Patent and Trademark Office (PTO) awarded the company Patent No. 8,840,555 on ultrasound technology for the dynamic functional analysis of injured and healing tissues.  The company’s Echosoft product line centers on the use of ultrasound to provide functional information about soft tissues as an alternative to other more expensive and less portable medical imaging modalities like MRI.

Key Points:

– U.S. Patent No. 8,840,555 covers ultrasound systems that track motion in dynamic ultrasound images to objectively analyze the functionality of tissues of interest.

– Current ultrasound evaluation of musculoskeletal tissues lacks a standardized, objective means of tissue functionality determination.  The technology protected in Patent No. 8,840,555 fills that gap by providing easily interpreted color maps and objective scores to assess tissue injury and extent of healing.

– Patent joins a small, but growing IP portfolio of U.S., European, and Japanese patents that protect the company’s ability to commercially market its product once cleared by regulatory agencies.

– U.S. Patent No. 8,840,555 is the first patent assigned to company and represents strong validation of the innovative technology the company is developing.

“The issuance of this patent will have broad-reaching effects in clinical and veterinary medicine, as well as in research into new musculoskeletal treatments.  It is an important step in translating the foundational patents that the company licenses from the Wisconsin Alumni Research Foundation into a commercializable product,” said Echometrix Chief Executive Jeff Dalsin.


About Echometrix LLC

Echometrix is a Madison-based developer of proprietary ultrasound technology focused on catalyzing penetration into the market for musculoskeletal ultrasound. The company’s products, based in part on UW-Madison technology licensed from the Wisconsin Alumni Research Foundation (WARF), will improve the speed, convenience, and efficacy of musculoskeletal injury analysis and management, while lowering costs compared to other imaging techniques. Early studies have demonstrated improved utility for injury assessment when compared with traditional ultrasound. The company is well positioned to address opportunities at the nexus of three growing markets: portable ultrasound, musculoskeletal imaging, and orthopedics. For more information, visit:


For more information or media inquiries, please contact Jeffrey Dalsin at or 708-955-8058.